Registry of Lobbyists
Innovative Medicines Canada / Médicaments novateurs Canada
| Subject matters | Details | Categories |
|---|---|---|
|
Federal-Provincial Relations, Foreign Affairs, Health, Industry, Intellectual Property, International Trade, Research and Development, Science and Technology, Small Business, Taxation and Finance
|
Annual federal Budgets and Budget updates as it relates to the biopharmaceutical industry
|
Legislative Proposal, Bill or Resolution
|
|
Foreign Affairs, Health, Infrastructure, International Trade, Natural Resources, Science and Technology, Small Business, Taxation and Finance
|
Biomanufacturing and Life Sciences Strategy (BLSS) as it relates to the biopharmaceutical industry
|
Policies or Program
|
|
Economic Development, Government Procurement, Health, International Development, International Relations, International Trade, Regional Development, Research and Development
|
Canada's Access to Medicines Regime with respect to ensuring that the program allows for the delivery of timely access to needed medicines to the developing world supported by a business climate in Canada that continues to encourage research into further treatment and prevention of disease
|
Policies or Program
|
|
Environment, Health, Science and Technology
|
Canadian Environmental Protection Act and Regulations in respect of modern, science-based regulations to reflect rapidly changing new technologies
|
Regulation, Legislative Proposal, Bill or Resolution
|
|
Economic Development, Health, Intellectual Property, Research and Development, Science and Technology
|
Canadian Institutes of Health Research (CIHR) Clinical Research Initiative as it relates to public/private research and development partnerships
|
Policies or Program
|
|
Consumer Issues, Federal-Provincial Relations, Intellectual Property, Science and Technology
|
Common Drug Review Policies as it relates to reimbursement recommendation decision-making process and framework
|
Policies or Program
|
|
Consumer Issues, Health, Intellectual Property, Research and Development
|
Food and Drug Regulations as it relates to data protection and the regulation and protection of biopharmaceutical products
|
Regulation
|
|
Health, Intellectual Property, International Relations, International Trade, Taxation and Finance
|
Food and Drugs Act and Regulations and the Import and Export Permits Act with respect to cross-border trade as it relates to the export of Canadian biopharmaceuticals
|
Regulation, Legislative Proposal, Bill or Resolution
|
|
Health, Intellectual Property, International Relations, International Trade, Taxation and Finance
|
Free trade treaty agreement as they relate to The Canada-United States-Mexico Agreement (CUSMA) and free trade negotiations as it relates to India, the European Union, Japan, MERCOSUR and the Trans-Pacific Partnership
|
Policies or Program
|
|
Health, Industry, Intellectual Property, International Trade, Research and Development, Taxation and Finance
|
Patent Act as it relates to reporting requirements and pricing guidelines, and the protection of intellectual property in biopharmaceutical products
|
Legislative Proposal, Bill or Resolution
|
|
Health, Intellectual Property, Research and Development, Taxation and Finance
|
Patented Medicines (Notice of Compliance) Regulations as it relates to the regulation of intellectual property for biopharmaceutical products
|
Regulation
|
|
Health, Intellectual Property, International Development, International Relations, International Trade, Taxation and Finance
|
Patented Medicines (Notice of Compliance) Regulations with respect to ensuring that patent rights are respected and are internationally competitive
|
Regulation
|
|
Health, Industry, Intellectual Property, International Development, International Relations, International Trade, Research and Development
|
Patented Medicines Regulations as it relates to the regulation and protection of biopharmaceutical products
|
Regulation
|
|
Consumer Issues, Health, Industry, Intellectual Property, International Development, International Relations, International Trade, Taxation and Finance
|
Pharmaceutical pricing policy issues arising from the jurisdiction of the Patented Medicines Prices Review Board (PMPRB)
|
Policies or Program
|
|
Constitutional Issues, Consumer Issues, Federal-Provincial Relations, Government Procurement, Health, Industry
|
Proposed pharmacare legislation related to any future national pharmacare program
|
Legislative Proposal, Bill or Resolution
|
|
Economic Development, Intellectual Property, Research and Development, Science and Technology, Taxation and Finance
|
Scientific Research and Experimental Development (SR&ED) Tax Credit in respect of updating the system and increasing the expenditure limit for refundable credits
|
Policies or Program
|